MVA-BN-HER2

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMVA-BN-HER2
Drug Alias NameHER-2 DNA AutoVacMVA-BN BreastMVA-BN/Her-2/NeuPX-1032PX-103.2
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharmexa AsBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBavarian Nordic A/S
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A